Get started
Author

M. Jane Ehrke

Observed names: M Ehrke, M J Ehrke, M Jane Ehrke, M. J. Ehrke, M. JANE EHRKE, M. Jane Ehrke1, M.J Ehrke, M.J. EHRKE, M.J. Ehrke, M.Jane Ehrke
OpenAlex ID: A5113696003
Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma.
2005 · Andrew Ewens, Enrico Mihich, et al. · PubMed · 151
Immunomodulation in cancer therapeutics
2003 · M.Jane Ehrke · International Immunopharmacology · 99
Effects of anticancer drugs on the immune system in humans.
1989 · M J Ehrke, E Mihich, et al. · PubMed · 89
Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance
1996 · Peter Ujházy, Erica S. Berleth, et al. · International Journal of Cancer · 81
PDF
Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
1987 · K Hori, M J Ehrke, et al. · PubMed · 72
Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice.
1986 · M J Ehrke, D Maccubbin, et al. · PubMed · 68
Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha.
1992 · S Verstovsek, D Maccubbin, et al. · PubMed · 66
Doxorubicin plus Interleukin-2 Chemoimmunotherapy against Breast Cancer in Mice
2006 · Andrew Ewens, Liqun Luo, et al. · Cancer Research · 65
Adriamycin-induced modulation of host defenses in tumor-bearing mice.
1992 · D L Maccubbin, K R Wing, et al. · PubMed · 65
Role of tumor necrosis factor in macrophage activation and tumoricidal activity.
1988 · K F Mace, M J Ehrke, et al. · PubMed · 62
Selective Effects of Adriamycin on Murine Host Defense Systems
1982 · M. Jane Ehrke, Stefan A. Cohen, et al. · Immunological Reviews · 57
Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells
2003 · Peter Ujhazy, Gintaras Zaleskis, et al. · Cancer Immunology Immunotherapy · 50
Doxorubicin-induced DNA degradation in murine thymocytes.
1994 · G Zaleskis, E Berleth, et al. · Molecular Pharmacology · 47
Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture.
1984 · M J Ehrke, K Ryoyama, et al. · PubMed · 47
Ecto‐5'‐nucleotidase (CD73) in multidrug‐resistant cell lines generated by doxorubicin
1994 · Peter Ujházy, Margita Klobušická, et al. · International Journal of Cancer · 45
Inhibition of the development of suppressor cells in culture by 4-hydroperoxycyclophosphamide
1984 · J W Cowens, H Ozer, et al. · The Journal of Immunology · 43
Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin.
1988 · K Mace, E Mayhew, et al. · PubMed · 41
Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
1987 · K Hori, M J Ehrke, et al. · PubMed · 38
Modification of host antitumor defense mechanisms in mice by progressively growing tumor.
1989 · D L Maccubbin, K F Mace, et al. · PubMed · 36
Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
1989 · K Hori, E Mihich, et al. · PubMed · 36
The effect of PS-K, a protein bound polysaccharide, on immune responses against allogeneic antigens
1983 · M. Jane Ehrke, Jane M. Reino, et al. · International Journal of Immunopharmacology · 36
Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
1981 · V Tomazic, M J Ehrke, et al. · PubMed · 36
Species-specific TNF induction of thymocyte proliferation
1988 · M.Jane Ehrke, RichardL.X. Ho, et al. · Cancer Immunology Immunotherapy · 33
Modulation of the cytotoxic response against allogeneic tumor cells in culture by adriamycin.
1980 · V Tomazic, M J Ehrke, et al. · PubMed · 30
Protective specific immunity induced by doxorubicin plus TNF-α combination treatment of EL4 lymphoma-bearing C57BL/6 mice
2000 · M. Jane Ehrke, Srdan Verstovšek, et al. · International Journal of Cancer · 27
Works count: 102
Citation count: 2,042
H-index: 25
I10-index: 52
Year
Topic
Type